Biocon Limited
BIOCON
Rank in Stocks
#3391
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Share Price
$3.76
Last synced: 2026-10-19
Market Cap
$5.14B
Change (1 day)
-2.11%
Change (1 year)
-9.31%
Country
IN
Trade Biocon Limited (BIOCON)
Category
Healthcare
Number of shares outstanding for Biocon Limited (BIOCON)
Number of shares outstanding as of June 2026: 1.62B
According to Biocon Limited latest financial reports and stock price the company's current number of shares outstanding is 1.62B. At the end of March 2024 the company had 1.20B shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Biocon Limited (BIOCON) from 2004 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 1.62B | 35.41% |
| 2025 | 1.20B | 0.15% |
| 2024 | 1.20B | 0.24% |
| 2023 | 1.19B | 0.17% |
| 2022 | 1.19B | 0.33% |
| 2021 | 1.19B | 0.25% |
| 2020 | 1.18B | 0.07% |
| 2019 | 1.18B | 0.29% |
| 2018 | 1.18B | 0.18% |
| 2017 | 1.18B | 0.00% |
| 2016 | 1.18B | -1.85% |
| 2015 | 1.20B | 1.92% |
| 2014 | 1.18B | 0.21% |
| 2013 | 1.17B | -0.04% |
| 2012 | 1.18B | 0.19% |
| 2011 | 1.17B | 0.54% |
| 2010 | 1.17B | 0.80% |
| 2009 | 1.16B | -0.13% |
| 2008 | 1.16B | -0.05% |
| 2007 | 1.16B | 1.13% |
| 2006 | 1.15B | 1.03% |
| 2005 | 1.14B | 11.70% |
| 2004 | 1.02B | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 253.90M | -84.34% |
US
|
|
| 396.00M | -75.58% |
US
|
|
| 478.91M | -70.47% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -96.17% |
NL
|
